EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process

Hye Ri Kim iD, Sun Mi Kim iD, Won Sub Kang iD, Hong Jun Jeon iD, Seung-Ho Jang iD, Duk-In Jon iD, Jeongwan Hong iD, Jong-Hyun Jeong iD

Clinical Psychopharmacology and Neuroscience · 31.08.2023 · 21 (3) · 447-456

DOI: 10.9758/cpn.22.979 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Psychopharmacology and Neuroscience, erschienen am 31.08.2023. Verfasst von Hye Ri Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Chung-Ang University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Psychosomatic Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Antipsychotic agentEvidence-based practiceGuidelineHyperprolactinemia

Autor:innen und Institutionen

  • Department of Psychiatry, Chung-Ang University College of Medicine, Seoul, Korea.
  • Department of Psychiatry, College of Medicine, Kyung Hee University, Seoul, Korea.
  • Department of Psychiatry, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Psychiatry, Wonkwang University School of Medicine, Iksan, Korea.
  • Department of Psychiatry, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
  • Department of Psychiatry, Iksan Hospital, Iksan, Korea.

ORCID-Profile: Hye Ri Kim, Sun Mi Kim, Won Sub Kang, Hong Jun Jeon, Seung-Ho Jang, Duk-In Jon, Jeongwan Hong, Jong-Hyun Jeong

Förderung

  • Korean Psychosomatic Society

Zitieren

APA

Kim, H. R., Kim, S. M., Kang, W. S., Jeon, H. J., Jang, S. H., Jon, D. I., Hong, J., & Jeong, J. H. (2023). Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process. Clinical Psychopharmacology and Neuroscience, 21(3), 447-456. https://doi.org/10.9758/cpn.22.979

Vancouver

Kim HR, Kim SM, Kang WS, Jeon HJ, Jang SH, Jon DI, et al. Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process. Clinical Psychopharmacology and Neuroscience. 2023;21(3):447-456. doi:10.9758/cpn.22.979

BibTeX
@article{Kim2023,
  author = {Kim, Hye Ri and Kim, Sun Mi and Kang, Won Sub and Jeon, Hong Jun and Jang, Seung-Ho and Jon, Duk-In and Hong, Jeongwan and Jeong, Jong-Hyun},
  title = {Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process},
  journal = {Clinical Psychopharmacology and Neuroscience},
  year = {2023},
  volume = {21},
  number = {3},
  pages = {447--456},
  doi = {10.9758/cpn.22.979}
}
Kostenlos starten →